Xavier Palazzi

Company: AstraZeneca

Job title: Vice President & Head of Global Pathology

Bio:

Xavier Palazzi is a veterinary pathologist and toxicologist with extensive experience in the field who currently leads the Pathology department within AstraZeneca Clinical Pharmacology and Safety Sciences, located in Boston. He holds a Doctorate of Veterinary Medicine from Ecole Nationale Vétérinaire de Lyon and has specialized in veterinary anatomic pathology and immunology. Xavier is dual-certified by the European College of Veterinary Pathology and the American Board of Toxicology.

His career spans leadership roles in prominent organizations such as Pfizer and Sanofi, where he managed global pathology and investigative toxicology operations, aligning resources with research unit needs and ensuring compliance with scientific and regulatory requirements. He has a robust publication record, contributing to scientific literature on topics like toxicologic pathology, neuroanatomy, and digital pathology advancements. Aside from his professional pursuits, he is an avid runner, sea kayaker, and model plane enthusiast.

Seminars:

Panel Discussion: Ensuring Fit for Purpose AI in Translational & Clinical Pathology to Accelerate Meaningful & Scalable Adoption 12:15 pm

How does biopharma define and measure whether a digital pathology tool is fit for its intended use case in drug development or diagnostics? What benchmarking strategies help distinguish generalizable models from those validated for specific clinical or biomarker contexts? How can pathologists and data scientists work together to align model development with real-world use requirements?Read more

day: Conference Day Two

Integrating AI-Powered Algorithms into Digital Pathology Workflows to Advance Preclinical Decision-Making & Toxicological Insights 11:45 am

Exploring how AI-powered tools are being embedded into digital pathology workflows to support faster, more consistent decision-making in preclinical research Highlighting strategies to improve the detection of tissue abnormalities and enhance pathology assessments through AI-driven insights Discussing the broader potential of AI integration to elevate translational research, accelerate drug development, and support regulatory readinessRead more

day: Conference Day Two